Anticancer activity studies of CUBEBIN (cas 18423-69-3) isolated from Piper cubeba and its synthetic derivatives

Add time:08/31/2019    Source:sciencedirect.com

(−)-CUBEBIN (cas 18423-69-3), isolated from the seeds of Piper cubeba, and its five different types of derivatives (a total of 17), with varying functionalities, were tested for their in vitro anticancer activity against six human cancer cell lines (A549, K562, SiHa, KB, HCT116 and HT29) using MTT assay. Cubebin as well as its derivatives containing lactone and amide groups showed significant anticancer activity. In some of the tested cell lines, the amide derivatives showed higher activity. Morphological analysis indicated that these compounds act through apoptosis mediated pathway of cell death and we expect that these results will pave new paths in the development of novel anticancer agents by the derivatization of (−)-cubebin.

We also recommend Trading Suppliers and Manufacturers of CUBEBIN (cas 18423-69-3). Pls Click Website Link as below: cas 18423-69-3 suppliers

Prev:Regular ArticlePalindromic Oligonucleotide-Directed Enzymatic Determination of 2′-Deoxythymidine 5′-Triphosphate and 2′-Deoxycytidine 5′-Triphosphate in Human Cells☆
Next:In vivo and in silico anti-inflammatory mechanism of action of the semisynthetic (−)-CUBEBIN (cas 18423-69-3) derivatives (−)-hinokinin and (−)-O-benzylCUBEBIN (cas 18423-69-3))